Literature DB >> 3880856

Insulin uptake by the human alcoholic cirrhotic liver.

A Nygren, N Adner, L Sundblad, K L Wiechel.   

Abstract

Insulin uptake by the human cirrhotic liver was studied in six patients with Laennec's cirrhosis, and the result was compared with that found in ten control patients with varying diseases affecting the biliary system. All patients had portal catheters for diagnostic purposes. The fractional hepatic uptake of insulin was calculated from the clearance rates for insulin obtained after a constant rate infusion into a peripheral vein and the portal vein in each patient. The fractional hepatic extraction of insulin was 13% +/- 5 in cirrhotic patients and differed significantly from the fractional hepatic extraction found in controls (51% +/- 5;P less than 0.001).

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3880856     DOI: 10.1016/0026-0495(85)90059-9

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  11 in total

1.  Studies on the mechanism of action of sulphonylureas in type II diabetic subjects: gliquidone.

Authors:  E Bonora; P Moghetti; M Querena; M Zenere; V Cacciatori; F Tosi; D Travia; G Zoppini; M Muggeo
Journal:  J Endocrinol Invest       Date:  1992-01       Impact factor: 4.256

2.  Mechanisms of hyperinsulinaemia in Child's disease grade B liver cirrhosis investigated in free living conditions.

Authors:  A V Greco; G Mingrone; A Mari; E Capristo; M Manco; G Gasbarrini
Journal:  Gut       Date:  2002-12       Impact factor: 23.059

3.  In vivo insulin action in hepatocellular and cholestatic liver cirrhosis.

Authors:  N Barzilai; P Cohen; E Karnieli; R Enat; O Epstein; J Owen; N McIntyre
Journal:  J Endocrinol Invest       Date:  1991-10       Impact factor: 4.256

4.  Insulin sensitivity, insulin secretion and glucose effectiveness in diabetic and non-diabetic cirrhotic patients.

Authors:  Y T Kruszynska; D S Harry; R N Bergman; N McIntyre
Journal:  Diabetologia       Date:  1993-02       Impact factor: 10.122

5.  A profile of impaired insulin degradation in relation to late-life cognitive decline: a preliminary investigation.

Authors:  Olivia I Okereke; Dennis J Selkoe; Michael N Pollak; Meir J Stampfer; Frank B Hu; Susan E Hankinson; Francine Grodstein
Journal:  Int J Geriatr Psychiatry       Date:  2009-02       Impact factor: 3.485

6.  Changes in immunoreactive insulin, C-peptide immunoreactivity, and immunoreactive glucagon in acute viral hepatitis.

Authors:  K Kaneko; M Arai; H Funatomi; Y Hatta; K Mitamura
Journal:  J Gastroenterol       Date:  1995-10       Impact factor: 7.527

7.  Alcohol consumption impairs hepatic protein trafficking: mechanisms and consequences.

Authors:  Blythe D Shepard; David J Fernandez; Pamela L Tuma
Journal:  Genes Nutr       Date:  2009-11-05       Impact factor: 5.523

8.  Hepatitis C comorbidities affecting the course and response to therapy.

Authors:  Abdel-Rahman El-Zayadi
Journal:  World J Gastroenterol       Date:  2009-10-28       Impact factor: 5.742

9.  Effect of physiologic hyperinsulinemia on glucose and lipid metabolism in cirrhosis.

Authors:  A S Petrides; L C Groop; C A Riely; R A DeFronzo
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

10.  Plasma betatrophin levels in patients with liver cirrhosis.

Authors:  Maria Teresa Arias-Loste; Maria Teresa García-Unzueta; Susana Llerena; Paula Iruzubieta; Angela Puente; Joaquín Cabezas; Carmen Alonso; Antonio Cuadrado; José Antonio Amado; Javier Crespo; Emilio Fábrega
Journal:  World J Gastroenterol       Date:  2015-10-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.